Association between BRCA1 P871L polymorphism and cancer risk: evidence from a meta-analysis

作者：Miao, Limin; Yu, Yang; Ji, Yefeng; Zhang, Bo; Yuan, Zhiyao; Du, Yifei; Zhu, Longbiao; Wang, Ruixia; Chen, Ning; Yuan, Hua^*

来源：Oncotarget, 2017, 8(18): 30587-30594.

DOI：10.18632/oncotarget.15739

• BRCA1
• polymorphism
• cancer risk
• meta-analysis

Breast cancer 1 (BRCA1) gene makes great contributions to the repair of DNA. The association between BRCA1 P871L polymorphism and cancer risk has been investigated in a growing number of studies, but the conclusions are not conclusive. To obtain a comprehensive conclusion, we performed a meta-analysis of 24 studies with 13762 cases and 22388 controls. The pooled results indicated that BRCA1 gene P871L variant decreased risk of overall cancer (homozygous model: odds ratio (OR) = 0.89, 95% confidence interval (CI) = 0.79-1.00; recessive model: OR = 0.89, 95% CI = 0.80-0.99). The stratified analysis observed decreased risk associated with BRCA1 P871L in subgroups among Asians and high score studies, but not Caucasians or low score studies. In conclusion, despite several limitations, this meta-analysis suggested that BRCA1 P871L genetic variation may be associated with decreased susceptibility to cancer.

• 出版日期2017-5-2
• 单位南京医科大学